United Asset Strategies’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$18.5M Sell
143,654
-66,781
-32% -$7.82M 1.3% 19
2026
Q1
$25.3M Sell
210,435
-6,760
-3% -$780K 2.01% 8
2025
Q4
$22.9M Buy
217,195
+26,930
+14% +$2.53M 1.76% 11
2025
Q3
$16M Buy
190,265
+21,765
+13% +$1.79M 1.28% 21
2025
Q2
$13.3M Buy
168,500
+55,611
+49% +$4.42M 1.14% 25
2025
Q1
$10.1M Buy
112,889
+16,712
+17% +$1.56M 0.94% 36
2024
Q4
$9.57M Buy
96,177
+381
+0.4% +$39.3K 0.88% 37
2024
Q3
$10.9M Buy
95,796
+3,913
+4% +$465K 1.01% 33
2024
Q2
$11.4M Buy
91,883
+1,565
+2% +$202K 1.12% 32
2024
Q1
$11.9M Sell
90,318
-3,182
-3% -$392K 1.19% 30
2023
Q4
$10.2M Buy
93,500
+6,045
+7% +$627K 1.15% 32
2023
Q3
$9M Buy
87,455
+2,518
+3% +$271K 1.16% 29
2023
Q2
$9.8M Sell
84,937
-199
-0.2% -$22.6K 1.22% 27
2023
Q1
$9.06M Sell
85,136
-23,869
-22% -$2.58M 1.2% 27
2022
Q4
$12.1M Buy
109,005
+78,246
+254% +$8M 1.69% 15
2022
Q3
$2.65M Sell
30,759
-28
-0.1% -$2.5K 0.41% 62
2022
Q2
$2.81M Sell
30,787
-1,082
-3% -$95.9K 0.41% 61
2022
Q1
$2.62M Buy
31,869
+7,863
+33% +$620K 0.33% 68
2021
Q4
$1.84M Buy
24,006
+17,506
+269% +$1.39M 0.22% 82
2021
Q3
$488K Buy
6,500
+50
+0.8% +$3.8K 0.06% 147
2021
Q2
$502K Sell
6,450
-524
-8% -$39K 0.07% 144
2021
Q1
$513K Sell
6,974
-735
-10% -$54.2K 0.07% 143
2020
Q4
$602K Buy
7,709
+117
+2% +$8.95K 0.09% 137
2020
Q3
$601K Sell
7,592
-761
-9% -$59.6K 0.11% 120
2020
Q2
$616K Sell
8,353
-102
-1% -$7.68K 0.12% 115
2020
Q1
$621K Sell
8,455
-1,346
-14% -$106K 0.15% 111
2019
Q4
$851K Sell
9,801
-626
-6% -$51.4K 0.17% 111
2019
Q3
$838K Buy
10,427
+4,800
+85% +$385K 0.18% 103
2019
Q2
$450K Buy
5,627
+419
+8% +$32.1K 0.1% 143
2019
Q1
$413K Sell
5,208
-102
-2% -$7.63K 0.1% 153
2018
Q4
$387K Buy
5,310
+248
+5% +$17.5K 0.11% 144
2018
Q3
$343K Sell
5,062
-108
-2% -$6.88K 0.08% 161
2018
Q2
$299K Buy
5,170
+2
+0% +$113 0.08% 169
2018
Q1
$269K Sell
5,168
-731
-12% -$39.5K 0.08% 168
2017
Q4
$317K Buy
+5,899
New +$327K 0.09% 160
2017
Q3
Sell
-5,738
Closed -$351K 150
2017
Q2
$351K Buy
5,738
+3
+0.1% +$183 0.1% 117
2017
Q1
$348K Sell
5,735
-1,096
-16% -$66.5K 0.11% 108
2016
Q4
$384K Sell
6,831
-18
-0.3% -$1.05K 0.13% 107
2016
Q3
$408K Buy
6,849
+348
+5% +$20.4K 0.14% 101
2016
Q2
$357K Buy
6,501
+695
+12% +$37K 0.13% 102
2016
Q1
$293K Sell
5,806
-1,958
-25% -$95.9K 0.13% 101
2015
Q4
$391K Sell
7,764
-717
-8% -$36.1K 0.17% 96
2015
Q3
$400K Buy
8,481
+2,587
+44% +$137K 0.18% 91
2015
Q2
$320K Sell
5,894
-278
-5% -$15.6K 0.14% 102
2015
Q1
$351K Sell
6,172
-81
-1% -$4.59K 0.16% 94
2014
Q4
$339K Buy
6,253
+154
+3% +$8.58K 0.14% 95
2014
Q3
$345K Sell
6,099
-501
-8% -$28.1K 0.15% 99
2014
Q2
$364K Buy
6,600
+1,020
+18% +$55.6K 0.18% 89
2014
Q1
$302K Buy
+5,580
New +$289K 0.17% 89

Other funds holding MRK

United Asset Strategies's MRK Position: Q2 2026 in Review

United Asset Strategies reduced its Merck (MRK) stake by 32% in Q2 2026, selling an estimated $7.82M and leaving 143,654 shares worth $18.5M. The position accounts for 1.3% of the portfolio, ranked #19.

United Asset Strategies first reported a position in MRK in Q1 2014 and has held it in 49 quarters since. The position peaked at $25.3M in Q1 2026. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • United Asset Strategies held 143,654 shares of Merck worth $18.5M as of Q2 2026.
  • United Asset Strategies sold 66,781 Merck shares in Q2 2026, an estimated $7.82M.
  • Merck made up 1.3% of United Asset Strategies's portfolio in Q2 2026, its #19 holding.
  • United Asset Strategies first reported a position in Merck in Q1 2014 and has held it in 49 quarters since.
  • United Asset Strategies's Merck position peaked at $25.3M in Q1 2026.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on United Asset Strategies's 13F filing for Q2 2026, filed 13 Jul 2026.